Haptena Therapeutics, a biotech focused on KRAS-mutated tumors, launched operations and secured €3 million from Claris Ventures. Founded by Chiara Ambrogio and Roberto Chiarle, the company...
The capital raised by Kither Biotech will be used to fund the development of Kither's lead product (Kit2014), a novel cell-permeable peptide for the treatment of...
Claris Ventures, founded by Pietro Puglisi and Ciro Spedaliere, is thus confirmed as one of the main Italian operators with a focus on early-stage biotech, a...